Global MicroRNA Market was valued around US$ XX Mn by 2018 and growing at a significant CAGR over next seven years 2019-2025

Global MicroRNA Market was Valued at US$ XX Mn in 2018, Increase in the Adoption of MicroRNA as Biomarker
Analyst Speak:

“The Global MicroRNA Market was valued around US$ XX Mn by 2018 and growing at a significant CAGR over next seven years 2019-2025 owing to increase in the adoption of microRNA as biomarker by biopharmaceutical and biotechnology companies”

The global microRNA market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years owing to rise in demand for the microRNA from biological industries coupled with diversified applications with the microRNAs. In addition, increase in the investment for the biotechnology R&D activities, rise in prevalence of chronic diseases such as cancer and diabetes, and technological advancements in the gene sequencing are attributed to drive the global microRNA market over the forecast years. However, lack of sophisticated laboratory infrastructure in underdeveloped countries, high cost of kits and reagents, and dearth of skilled professionals are hamper the global microRNA market over the forecast timeframe

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/microrna-market/#ulp-4H8Z4LpNMLEuOnnx

Global MicroRNA market segmented on the basis of product type, technology, application, end user, and region

PCR-Based Assay A Dominate the Global MicroRNA Market

Based on the technology, global microRNA market segmented into microarray, PCR-based assay, extraction tools, functional analysis tools, and others. PCR-based assay technique dominate the global microRNA market owing to development of advanced technologies such as quantitative PCR, digital PCR, and endpoint PCR.
North America Leads the Global MicroRNA market

PBI’s global microRNA market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing development of advancements for the microRNA sequencing, fundraising by the public and private sectors for the R&D activities in biotechnology, and rise in prevalence of chronic diseases are propel the market. Europe microRNA market projected to exhibit significant growth due to adoption of advanced technologies, sophisticated healthcare infrastructure, and rise in demand for personalized medicine are expected to bolster the market.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/microrna-market/#ulp-c654SbFYO64MsOhu

Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

Global microRNA market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In April 2014, Exigon launched high potent microRNA, miRCURY LNA used for the functional analysis.

Key player’s profiles in the report are Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Exiqon) (Germany), Illumina, Inc. (U.S.), GE Healthcare (UK), Agilent Technologies (U.S.), GeneCopoeia, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Promega Corporation (U.S.), and Merck & Co., Inc. (U.S.)

Precision Business Insights (PBI) in its report titled “Global MicroRNA Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/microrna-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Product Type
o Instruments
o Reagents and Kits
o Services
• Sequencing Services
• Quantification Services
• MicroRNA Extraction Services
• Microarray Services
• Others
By Technology
o PCR-Based Assay
o Microarray
o Functional Analysis Tools
o Extraction Tools
o Next Generation Sequencing
o Others
By Application
o Cardiovascular Diseases
o Neurological Diseases
o Immunological Diseases
o Cancers
o Others
By End User
o Biopharmaceutical and Biotechnology Companies
o Contract Research Organizations
o Academic and Research Institutes
o Others
Geography
o North America
• U.S
• Canada
o Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
o Latin America
• Brazil
• Mexico
• Argentina
• Venezuela
• Rest of Latin America
o Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/microrna-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.